FDA Complaint for Public Comment

The Food and Drug Administration (FDA) has issued a complaint, designated as FDA-2026-H-2192-0001, which is now open for public comment. The complaint was authored by the CTP (likely Center for Tobacco Products, given the context of FDA regulations) and is available for review and download.

Regulated entities, particularly drug manufacturers and pharmaceutical companies, should review the complaint to understand the specific issues raised and to prepare any necessary responses. The deadline for submitting comments is March 13, 2026. Failure to respond or address the concerns outlined in the complaint could lead to potential enforcement actions or regulatory scrutiny.